Our Unified Agentic Framework is purpose-built for hospitals, labs, and revenue cycle teams who rely on ADT feeds, HL7 messaging, DICOM workflows, and 837 claims data. By integrating these disparate streams through rigorous clinical validation and interoperability, we deliver the evidence-based reliability needed to turn fragmented signals into mission-critical foresight across:
Healthcare Use Cases
Each Prajna AI capability is validated through high-fidelity simulations designed to reflect real healthcare operating conditions.
From Encounter Records to Early Clinical Signals: Transforming Care Pattern Visibility with AINalyzer
- Time-consuming compound screening
- Inefficient molecular property prediction
- Challenges optimizing clinical trial sites
- Difficulty synthesizing vast biomedical knowledge
- Manual and error-prone data analysis
- Slow and costly clinical trial processes
At a Glance
- GrasPh
- DocuDigest
- DocGenetiX
Our Solutions
- Shorten R\&D cycles and improve clinical outcomes with AI-powered drug discovery platforms. Our system identifies promising compounds, predicts molecular efficacy, and optimizes trial site selection—enhancing precision medicine while reducing research costs and timelines.
Our Solution offers:
- Slow adverse event detection
- Inconsistent regulatory document formats
- Challenges monitoring evolving labeling compliance
- Risk of non-compliance and penalties
- Manual review of vast regulatory data
Key Pain Points:
- DocuDigest
- DocGenetiX
- VisionIQ
Our Solutions
- Ensure seamless regulatory compliance with AI-enabled monitoring and reporting tools. Our solutions automate adverse event detection, streamline submission workflows, and highlight labeling gaps—minimizing regulatory risks and improving pharmacovigilance efficiency.
Our Solution offers:
- Difficulty reaching target audiences effectively
- Inaccurate supply chain demand forecasting
- Difficulty adapting to market changes
- Manual data analysis for commercial insights
Key Pain Points:
- AutoInsight
- AINalyzer
- Grasph
Our Solutions
- Boost market performance with AI-enhanced sales optimization tools. Our platform delivers real-time insights into demand, inventory, and field performance—helping life sciences companies adapt faster to market changes and improve commercial outcomes.
Our Solution offers:
- Tedious manual literature review
- Difficulty identifying influential Key Opinion Leader (KOLs)
- Challenges performing comprehensive post-market safety analysis
- Slow generation of real-world evidence
- Lack of real-time insights from vast medical literature
Key Pain Points:
- AutoInsight
- VisionIQ
- AINalyzer
- DocuDigest
Our Solutions
- Empower medical affairs teams with AI solutions for rapid evidence synthesis and KOL engagement. Our tools extract insights from scientific literature, monitor safety signals, and support post-market research—enabling informed decisions and regulatory alignment.
Our Solution offers:
- Time-consuming compound screening
- Inefficient molecular property prediction
- Challenges optimizing clinical trial sites
- Difficulty synthesizing vast biomedical knowledge
- Manual and error-prone data analysis
- Slow and costly clinical trial processes
Key Pain Points:
- GrasPh
- DocuDigest
- DocGenetiX
Our Solutions
- Shorten R\&D cycles and improve clinical outcomes with AI-powered drug discovery platforms. Our system identifies promising compounds, predicts molecular efficacy, and optimizes trial site selection—enhancing precision medicine while reducing research costs and timelines.
Our Solution offers:
- Slow adverse event detection
- Inconsistent regulatory document formats
- Challenges monitoring evolving labeling compliance
- Risk of non-compliance and penalties
- Manual review of vast regulatory data
Key Pain Points:
- DocuDigest
- DocGenetiX
- VisionIQ
Our Solutions
- Ensure seamless regulatory compliance with AI-enabled monitoring and reporting tools. Our solutions automate adverse event detection, streamline submission workflows, and highlight labeling gaps—minimizing regulatory risks and improving pharmacovigilance efficiency.
Our Solution offers:
- Difficulty reaching target audiences effectively
- Inaccurate supply chain demand forecasting
- Difficulty adapting to market changes
- Manual data analysis for commercial insights
Key Pain Points:
- AutoInsight
- AINalyzer
- Grasph
Our Solutions
- Boost market performance with AI-enhanced sales optimization tools. Our platform delivers real-time insights into demand, inventory, and field performance—helping life sciences companies adapt faster to market changes and improve commercial outcomes.
Our Solution offers:
- Tedious manual literature review
- Difficulty identifying influential Key Opinion Leader (KOLs)
- Challenges performing comprehensive post-market safety analysis
- Slow generation of real-world evidence
- Lack of real-time insights from vast medical literature
Key Pain Points:
- AutoInsight
- VisionIQ
- AINalyzer
- DocuDigest
Our Solutions
- Empower medical affairs teams with AI solutions for rapid evidence synthesis and KOL engagement. Our tools extract insights from scientific literature, monitor safety signals, and support post-market research—enabling informed decisions and regulatory alignment.
Our Solution offers:
- Manual and time-consuming radiology interpretation
- Challenges with large-scale pathology slide analysis
- Limited bedside diagnostic support
- Potential for human error in image analysis
- Slow turnaround times for critical diagnoses
Key Pain Points:
- ImaGenetiX
- VizAIo
- GrasPh
Our Solutions
- Improve diagnostic accuracy and speed with AI-powered medical imaging analysis. Our system supports radiology, pathology, and point-of-care diagnostics—reducing errors and accelerating clinical decisions across a variety of healthcare settings.
Our Solution offers: